Olivotto I - Search Results

1

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.

Hegde SM, Lester SJ, Solomon SD, Michels M, Elliott PM, Nagueh SF, Choudhury L, Zemanek D, Zwas DR, Jacoby D, Wang A, Ho CY, Li W, Sehnert AJ, Olivotto I, Abraham TP. Hegde SM, et al. Among authors: olivotto i. J Am Coll Cardiol. 2021 Dec 21;78(25):2518-2532. doi: 10.1016/j.jacc.2021.09.1381. J Am Coll Cardiol. 2021. PMID: 34915982 Free article. Clinical Trial.

2

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Cecchi F, et al. Among authors: olivotto i. J Am Coll Cardiol. 1995 Nov 15;26(6):1529-36. doi: 10.1016/0735-1097(95)00353-3. J Am Coll Cardiol. 1995. PMID: 7594081 Free article.

3

Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction.

Dutka DP, Olivotto I, Ward S, Oakley CM, Impallomeni M, Cleland JG. Dutka DP, et al. Among authors: olivotto i. Am J Cardiol. 1996 Jun 1;77(14):1197-201. doi: 10.1016/s0002-9149(96)00162-2. Am J Cardiol. 1996. PMID: 8651095

4

Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function.

Lorenzoni R, Gistri R, Cecchi F, Olivotto I, Chiriatti G, Elliott P, McKenna WJ, Camici PG. Lorenzoni R, et al. Among authors: olivotto i. Eur Heart J. 1997 Dec;18(12):1946-50. doi: 10.1093/oxfordjournals.eurheartj.a015204. Eur Heart J. 1997. PMID: 9447323

5

Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction.

Lorenzoni R, Gistri R, Cecchi F, Olivotto I, Chiriatti G, Elliott P, McKenna WJ, Camici PG. Lorenzoni R, et al. Among authors: olivotto i. Am Heart J. 1998 Dec;136(6):972-81. doi: 10.1016/s0002-8703(98)70152-8. Am Heart J. 1998. PMID: 9842009

6

Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.

Olivotto I, Montereggi A, Mazzuoli F, Cecchi F. Olivotto I, et al. G Ital Cardiol. 1999 Jan;29(1):11-9. G Ital Cardiol. 1999. PMID: 9987042

7

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Olivotto I, et al. J Am Coll Cardiol. 1999 Jun;33(7):2044-51. doi: 10.1016/s0735-1097(99)00094-7. J Am Coll Cardiol. 1999. PMID: 10362212 Free article.

8

[Therapy of hypertrophic cardiomyopathy].

Cecchi F, Olivotto I. Cecchi F, et al. Among authors: olivotto i. G Ital Cardiol. 1999 Oct;29(10):1199-203. G Ital Cardiol. 1999. PMID: 10546134 Italian. No abstract available.

9

Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Cecchi F. Olivotto I, et al. Curr Cardiol Rep. 2001 Mar;3(2):141-6. doi: 10.1007/s11886-001-0041-x. Curr Cardiol Rep. 2001. PMID: 11177672 Review.

10

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, Casey SA, Gohman TE, Bongioanni S, Spirito P. Maron BJ, et al. Among authors: olivotto i. J Am Coll Cardiol. 2002 Jan 16;39(2):301-7. doi: 10.1016/s0735-1097(01)01727-2. J Am Coll Cardiol. 2002. PMID: 11788223 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

759 results

Search Page